New Release: "Immunization
Safety Review: Multiple Immunizations and Immune
Dysfunction", a report from the Institute of Medicine. (http://www.iom.edu/imsafety)
This report summarizes the current state of evidence from
scientific studies examining the possibility of a causal link
between immunizations and immune dysfunction. The report
illustrates that there is some biological plausibility and some
epidemiologic evidence for links between multiple vaccines and
adverse health effects, but that there is much uncertainty in this
area of scientific inquiry and that much more research needs to be
done before we can definitively rule in or rule out causal
associations. At the very least, all health professionals should
read the executive summary of this report. The IOM committee that
synthesized the scientific evidence on vaccination risks and
benefits, also recommends in this report that another committee
should be convened expressly for the purpose of presenting this
complex scientific information in a way that can be more easily
read and understood by patients and "typical" health
care consumers.
Following are some relevant quotes from the report:
"Although the committee's review points to no causal
relationship between multiple immunizations and type 1 diabetes or
risk of infection, and the review is inconclusive for asthma, the
biological evidence does provide weak support for increased risk
of allergy and autoimmunity and strong support for increased risk
of infection. Further study of such associations poses difficult
scientific challenges, and relevant epidemiological evidence
remains limited. Several important scientific and policy issues,
therefore, deserve further public health attention."
"Current approaches to immunization policy-making
emphasize epidemiologic
and economic considerations, but may benefit from greater
attention to ethical issues, including personal liberty and equity
of allocation of the benefits and burdens of immunization. With
new vaccines in development and discussions of the wider use of
existing vaccines, more flexible approaches to immunization
policies -- especially regarding priorities -- may be
needed."
"The committee recommends a panel of multidisciplinary
experts be convened by the DHHS to design a comprehensive research
strategy to compile sufficient and complementary knowledge to use
as a basis for designing and evaluating vaccine risk-benefit
communication approaches."